PT-141, also known as Bremelanotide, is a synthetic peptide studied for its activity as a melanocortin receptor agonist, particularly targeting melanocortin receptors involved in neurological and endocrine signaling pathways. In laboratory research, PT-141 is commonly used to investigate melanocortin receptor activity, neuropeptide signaling, and hormone-mediated physiological responses. This compound has gained interest in scientific studies exploring central nervous system signaling, receptor pharmacology, and peptide-based regulatory mechanisms.
This compound is supplied strictly for laboratory research purposes and is not intended for human or veterinary use, diagnostic procedures, or therapeutic applications. Tested in the United States 🇺🇸
